Director, Due Diligence and Integration

Director, Due Diligence and Integration

Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas:
Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company's success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

The Due Diligence and Integration Director is a key player responsible to drive the assessment of external programs/entities to support Ipsen's external innovation objectives. Once transacted, he/she would plan and lead the onboarding, transition, and integration of the acquired assets into the Ipsen ecosystem.

• Due Diligence:
• Direct key R&D stakeholders to ensure stage appropriate participation of relevant functions to support pre-DD assessment and drive confirmatory due diligence of external programs/entities
• Manage access to data rooms/internal repositories, and drive data request process to ensure thorough review of science, modality, MoA, clinical/regulatory viability, and CMC feasibility
• Structure and lead regular meetings and coordinate discussions with internal stakeholders, and external parties, as necessary
• Drive generation of integrated global development plan for the asset/s including risk-mapping and life-cycle management potential
• Collaborate with finance to generate development cost models; and provide Probability of Success matrix to support generation of business case and valuation models
• Summarize the assessment in a stage-gated manner to generate a consolidated cross-functional report including clear recommendations, interdependencies, risks profiles and mitigation plans
• Prepare and present material for various governance meetings to support decision making process
• Collaborate with deal team during confirmatory diligence, support preparation of transaction in accordance to deal rational, development plans, and financial models
• Track and manage archival of due diligence assignments supporting the M&A initiatives across all therapeutic areas
• Partner with the Ipsen due diligence community to ensure Ipsen processes/playbook and functional support remain state-of-the-art per industry standards
• Integration:
• Assemble onboarding package capturing all relevant due diligence material to support launch of project/asset teams
• Manage virtual data rooms including clean rooms/teams; facilitate the data request process pre-close
• Collaborate with Ipsen stakeholders including relevant corporate functions to define the integration objectives, formulate pre-integration/integration plans to meet these objectives in accordance with the deal model expectations
• Work closely with Finance to ensure development costs (external and internal) are appropriately reflected and accounted for the execution
• Support identification of areas for transition support, facilitate development of Transition Services Agreements including cost/resource requirements, and oversee administration of the services
• Partner with management and staff including that from the acquired businesses to execute integration plan, assimilate into Ipsen, and achieve targets during integration/transition phases
• Assist in execution of business initiatives during integration/transition period to ensure achievement of financial goals and leading indicators
• Serve as visible leader and representative from Ipsen to demonstrate culture, values of organization, and welcome new colleagues
• Partner with integration community to ensure the Ipsen processes/playbook remain state-of-the-art per industry standards

Knowledge &…